High incidence and frequency of LOH are associated with aggressive features of high-grade HER2 and triple-negative breast cancers

被引:11
|
作者
Tokunaga, Eriko [1 ]
Okada, Satoko [1 ]
Yamashita, Nami [1 ]
Akiyoshi, Sayuri [1 ]
Kitao, Hiroyuki [2 ]
Morita, Masaru [1 ]
Kakeji, Yoshihiro [1 ]
Maehara, Yoshihiko [1 ]
机构
[1] Kyushu Univ, Dept Surg & Sci, Grad Sch Med Sci, Higashi Ku, Fukuoka 8128582, Japan
[2] Kyushu Univ, Dept Mol Oncol, Grad Sch Med Sci, Fukuoka 8128582, Japan
关键词
Loss of heterozygosity; Human epidermal receptor-2; Triple-negative breast cancer; Genetic instability; Breast cancer subtype; FLUORESCENT MICROSATELLITE ANALYSIS; DINUCLEOTIDE REPEAT INSTABILITY; DNA MISMATCH REPAIR; GENOME-WIDE SEARCH; PROGESTERONE-RECEPTOR; GASTRIC-CANCER; HETEROZYGOSITY; EXPRESSION; CARCINOMA; BRCA1;
D O I
10.1007/s12282-010-0232-7
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Basal-like and HER2-overexpressing breast carcinomas are histologically undifferentiated, high-grade tumors with a high proliferation rate and associated with a poor outcome. Most basal-like tumors lack the expression of ER, PR, and HER2 (triple-negative; TN). Loss of heterozygosity (LOH) is thought to reflect random chromosomal instability, and recent studies have shown that DNA-copy number alterations or LOH occur with a high frequency in basal-like and HER2-amplified tumors. The levels and patterns of LOH were analyzed by the microsatellite alteration analysis using fluorescence-labeled primers and an automated DNA sequencer at 5 randomly selected loci in 246 Japanese primary breast cancers. Associations between the level of LOH and breast cancer subtypes and tumor aggressiveness were investigated. The incidence and frequency of LOH was significantly higher in HER2 (56.3, 26.7%) and TN groups (44.4, 27.1%) than in luminal A (ER-positive and/or PR-positive and HER2-negative) groups (32.0, 12.2%). The incidence and frequency of LOH increased as nuclear grade was elevated. There were significantly more grade 3 tumors in the HER2 (80.0%) and TN (68.2%) subgroups (p < 0.0001). Even in HER2 and TN cases, the incidence and frequency of LOH was significantly higher in nuclear grade 3 cases than in grade 1 or 2 cases. Relapse-free survival of patients with LOH was significantly shorter than for those without LOH. In addition, the survival time was shorter as the frequency of LOH elevated. The incidence of LOH was an independent prognostic factor for relapse-free survival by multivariate analysis. High incidence and frequency of LOH, which indicate increased genetic instability, were found to be associated with the aggressive features of high-grade HER2 and TN breast cancers.
引用
收藏
页码:161 / 169
页数:9
相关论文
共 50 条
  • [1] High incidence and frequency of LOH are associated with aggressive features of high-grade HER2 and triple-negative breast cancers
    Eriko Tokunaga
    Satoko Okada
    Nami Yamashita
    Sayuri Akiyoshi
    Hiroyuki Kitao
    Masaru Morita
    Yoshihiro Kakeji
    Yoshihiko Maehara
    Breast Cancer, 2012, 19 : 161 - 169
  • [2] SPONTANEOUS PATHOLOGICAL COMPLETE REGRESSION OF HIGH-GRADE TRIPLE-NEGATIVE BREAST CANCER WITH AXILLARY METASTASIS
    Cserni, Gabor
    Serfozo, Orsolya
    Ambrozay, Eva
    Marko, Laszlo
    Krenacs, Laszlo
    POLISH JOURNAL OF PATHOLOGY, 2019, 70 (02) : 139 - 143
  • [3] Histological Features and Tissue Microarray Taxonomy of Nigerian Breast Cancer Reveal Predominance of the High-Grade Triple-Negative Phenotype
    Titloye, N. A.
    Foster, A.
    Omoniyi-Esan, G. O.
    Komolafe, A. O.
    Daramola, A. O.
    Adeoye, O. A.
    Adisa, A. O.
    Manoharan, A.
    Pathak, D.
    D'Cruz, M. N.
    Alizadeh, Y.
    Lewis, P. D.
    Shaaban, A. M.
    PATHOBIOLOGY, 2016, 83 (01) : 24 - 32
  • [4] New Challenges in the Differential Diagnosis of High-Grade Triple-Negative Breast Cancer and Serous Carcinoma
    Puzyrenko, Andrii
    Cortina, Chandler S.
    Jorns, Julie M.
    INTERNATIONAL JOURNAL OF SURGICAL PATHOLOGY, 2022, 30 (07) : 728 - 733
  • [5] Epigenetic silencing of CREB3L1 by DNA methylation is associated with high-grade metastatic breast cancers with poor prognosis and is prevalent in triple negative breast cancers
    Ward, Alison K.
    Mellor, Paul
    Smith, Shari E.
    Kendall, Stephanie
    Just, Natasha A.
    Vizeacoumar, Frederick S.
    Sarker, Sabuj
    Phillips, Zoe
    Alvi, Riaz
    Saxena, Anurag
    Vizeacoumar, Franco J.
    Carlsen, Svein A.
    Anderson, Deborah H.
    BREAST CANCER RESEARCH, 2016, 18
  • [6] An easy and practical prognostic parameter: tumor-stroma ratio in Luminal, Her2, and triple-negative breast cancers
    Ozturk, Cigdem
    Okcu, Oguzhan
    Sen, Bayram
    Bedir, Recep
    REVISTA DA ASSOCIACAO MEDICA BRASILEIRA, 2022, 68 (02): : 227 - 233
  • [7] High incidence of triple negative breast cancers following pregnancy and an associated gene expression signature
    Asztalos, Szilard
    Pham, Thao N.
    Gann, Peter H.
    Hayes, Meghan K.
    Deaton, Ryan
    Wiley, Elizabeth L.
    Emmadi, Rajyasree
    Kajdacsy-Balla, Andre
    Banerji, Nilanjana
    McDonald, William
    Khan, Seema A.
    Tonetti, Debra A.
    SPRINGERPLUS, 2015, 4 : 1 - 9
  • [8] COX2 expression in high-grade breast cancer: evidence for prognostic significance in the subset of triple-negative breast cancer patients
    Chikman, Bar
    Vasyanovich, Sergey
    Lavy, Ron
    Habler, Liliana
    Tolstov, Gleb
    Kapiev, Andronik
    Halevy, Ariel
    Sandbank, Judith
    MEDICAL ONCOLOGY, 2014, 31 (06)
  • [9] Among triple-negative breast cancers, HER2(0) breast cancer shows a strong tendency to be basal-like compared with HER2(1+) breast cancer: preliminary results
    Nakagawa, Misako
    Bando, Yoshimi
    Nagao, Taeko
    Takai, Chikako
    Ohnishi, Takamasa
    Honda, Junko
    Moriya, Takuya
    Izumi, Keisuke
    Takahashi, Masako
    Tangoku, Akira
    Sasa, Mitsunori
    BREAST CANCER, 2012, 19 (01) : 54 - 59
  • [10] Among triple-negative breast cancers, HER2(0) breast cancer shows a strong tendency to be basal-like compared with HER2(1+) breast cancer: preliminary results
    Misako Nakagawa
    Yoshimi Bando
    Taeko Nagao
    Chikako Takai
    Takamasa Ohnishi
    Junko Honda
    Takuya Moriya
    Keisuke Izumi
    Masako Takahashi
    Akira Tangoku
    Mitsunori Sasa
    Breast Cancer, 2012, 19 : 54 - 59